Literature DB >> 15244239

Characteristics of respiratory syncytial virus-related apnoea in three infants.

M Rayyan1, G Naulaers, H Daniels, K Allegaert, A Debeer, H Devlieger.   

Abstract

UNLABELLED: Apnoea is a common sign in respiratory syncytial virus (RSV) infections in young infants and can be the first presentation of an acquired RSV infection. We describe polysomnographic recordings of three infants revealing prolonged RSV-related apnoea before RSV infection was diagnosed. The apnoeas were of central origin. The caregivers had not noted any apparent life-threatening events (ALTE) prior to the polysomnography. Cardiorespiratory monitoring after the acute infection did not reveal any further apnoeas.
CONCLUSION: Central, prolonged apnoea can be the first sign of an acquired RSV infection in young infants in the absence of other respiratory symptoms and without any previous observation of apnoea by the caregivers.

Entities:  

Mesh:

Year:  2004        PMID: 15244239

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  Impaired learning resulting from respiratory syncytial virus infection.

Authors:  Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Roberto S Gómez; Sebastián A Riquelme; Claudia M Cortés; Javier A Valenzuela; Rodrigo A Sandoval; Floria C Pancetti; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  Apnea in children hospitalized with bronchiolitis.

Authors:  Alan R Schroeder; Jonathan M Mansbach; Michelle Stevenson; Charles G Macias; Erin Stucky Fisher; Besh Barcega; Ashley F Sullivan; Janice A Espinola; Pedro A Piedra; Carlos A Camargo
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

Review 3.  Human Respiratory Syncytial Virus: Infection and Pathology.

Authors:  Karen Bohmwald; Janyra A Espinoza; Emma Rey-Jurado; Roberto S Gómez; Pablo A González; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.